EUVIMEDEUVIMED entdecken
Video/Audio

Clinical Observation of Adding Vitamin D to a Probucol-Based Regimen in Diabetic Nephropathy Patients

Qiong Liu, Nan Ding, Zhijuan Hu

Journal of Visualized Experiments · 2026

DOI: 10.3791/70901 ↗

Kurz gefasst

Video/Audio in der Zeitschrift Journal of Visualized Experiments, 2026. Verfasst von Qiong Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Hebei General Hospital; lq800813@163.com. Hauptthemen laut MEDLINE: Probucol, Diabetic Nephropathies, Vitamin D.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to investigate the therapeutic efficacy of vitamin D as an adjunct to probucol-based triple therapy (valsartan + atorvastatin + probucol) in patients with diabetic nephropathy (DN) and to evaluate its impact on immune function. A total of 150 DN patients (Mogensen stage III) were retrospectively enrolled from July 2022 to May 2024. Based on the different medication regimens received in clinical practice, they were divided into a control group (n = 56) receiving triple therapy (valsartan + atorvastatin + probucol) and an observation group (n = 94) receiving quadruple therapy (triple therapy + vitamin D). Group assignment was determined by the actual treatment administered, not by randomization. Both groups received daily insulin infusions concurrently for 8 months. Clinical parameters, including renal function (SCr, 24 h UPE, UAlb/UCR), glucose and lipid profiles, immune markers (CD3+, CD4+ cells, CD4+/CD8+ ratio), and inflammatory factors (hs-CRP, IL-6, TNF-α, MCP-1), were assessed pre- and post-treatment. Results demonstrated that the observation group showed significantly greater improvements in renal function, glycemic control, lipid profiles, and immune modulation (elevated proportions of CD3+ and CD4+, a higher CD4+/CD8+ ratio, and reduced inflammatory markers) compared with the control group (all P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbucolDiabetic NephropathiesVitamin DHumansFemaleMaleMiddle AgedDrug Therapy, CombinationValsartanAtorvastatinRetrospective StudiesAgedAnticholesteremic Agents

Substanzen

ProbucolVitamin DValsartanAtorvastatinAnticholesteremic Agents

Autor:innen und Institutionen

  • Department of Nephrology, Hebei General Hospital; lq800813@163.com.
  • Department of Clinical Laboratory, Hebei General Hospital.
  • Department of Nephrology, Hebei General Hospital.

Zitieren

APA

Liu, Q., Ding, N., & Hu, Z. (2026). Clinical Observation of Adding Vitamin D to a Probucol-Based Regimen in Diabetic Nephropathy Patients. Journal of Visualized Experiments. https://doi.org/10.3791/70901

Vancouver

Liu Q, Ding N, Hu Z. Clinical Observation of Adding Vitamin D to a Probucol-Based Regimen in Diabetic Nephropathy Patients. Journal of Visualized Experiments. 2026. doi:10.3791/70901

BibTeX
@article{Liu2026,
  author = {Liu, Qiong and Ding, Nan and Hu, Zhijuan},
  title = {Clinical Observation of Adding Vitamin D to a Probucol-Based Regimen in Diabetic Nephropathy Patients},
  journal = {Journal of Visualized Experiments},
  year = {2026},
  doi = {10.3791/70901}
}
Kostenlos starten →